These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9868423)

  • 1. Antifungal agents. Part I. Amphotericin B preparations and flucytosine.
    Patel R
    Mayo Clin Proc; 1998 Dec; 73(12):1205-25. PubMed ID: 9868423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal agents used for deep-seated mycotic infections.
    Hermans PE
    Mayo Clin Proc; 1977 Nov; 52(11):687-93. PubMed ID: 579245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel lipid delivery system of amphotericin B: drug profile and relevance to clinical practice.
    Rust DM; Jameson G
    Oncol Nurs Forum; 1998; 25(1):35-48. PubMed ID: 9460772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal agents used for deep-seated mycotic infections.
    Hermans PE; Keys TF
    Mayo Clin Proc; 1983 Apr; 58(4):223-31. PubMed ID: 6339832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of low-dose amphotericin B and flucytosine in the treatment of cryptococcal meningitis].
    Xu B; Wu JQ; Ou XT; Xie Y; Huang YX; Jiang WM; Jin JL; Zhu LP; Weng XH
    Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(6):379-81. PubMed ID: 20367933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal agents used for deep-seated mycotic infections.
    Terrell CL; Hermans PE
    Mayo Clin Proc; 1987 Dec; 62(12):1116-28. PubMed ID: 3682956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal agents used for deep-seated mycotic infections.
    Terrell CL; Hughes CE
    Mayo Clin Proc; 1992 Jan; 67(1):69-91. PubMed ID: 1732694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid formulations of amphotericin B: clinical perspectives for the management of invasive fungal infections in children with cancer.
    Groll AH; Müller FM; Piscitelli SC; Walsh TJ
    Klin Padiatr; 1998; 210(4):264-73. PubMed ID: 9743964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of amphotericin B, flucytosine and itraconazole with amphotericin B and flucytosine in the treatment of cryptococcal meningitis in AIDS.
    Chotmongkol V; Sukeepaisarncharoen W; Thavornpitak Y
    J Med Assoc Thai; 1997 Jul; 80(7):416-25. PubMed ID: 9277070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiology and therapy of mycotic infections in immunocompromised host with special regard to the role of lipid formulations of amphotericin B].
    Viscoli C; Castagnola E
    Recenti Prog Med; 1999 Oct; 90(10):545-57. PubMed ID: 10592741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungals in systemic neonatal candidiasis.
    Frattarelli DA; Reed MD; Giacoia GP; Aranda JV
    Drugs; 2004; 64(9):949-68. PubMed ID: 15101785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal treatment for cryptococcal meningitis.
    Powderly WG
    Intern Med J; 2006 Jul; 36(7):404-5. PubMed ID: 16780444
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety.
    Hamill RJ; Sobel JD; El-Sadr W; Johnson PC; Graybill JR; Javaly K; Barker DE
    Clin Infect Dis; 2010 Jul; 51(2):225-32. PubMed ID: 20536366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
    Schwarz P; Dromer F; Lortholary O; Dannaoui E
    Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
    Jaruratanasirikul S
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):719-23. PubMed ID: 9253873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neonatal candidiasis and liposomal amphotericin B treatment: our experience].
    Carrasco Sánchez P; Castillo Montero ML; Bejarano Palma A; López Sanz A; Santano Gallinato M; Sáenz Reguera C; Durán de Vargas L; González-Meneses A
    An Esp Pediatr; 1999 Sep; 51(3):273-80. PubMed ID: 10575751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic treatment of systemic candidiasis in newborns.
    Serra G; Mezzano P; Bonacci W
    J Chemother; 1991 Jan; 3 Suppl 1():240-4. PubMed ID: 12041777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the current and future status of conventional amphotericin B?
    Kleinberg M
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():12-6. PubMed ID: 16707251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal amphotericin B overdose due to administration of nonlipid formulation instead of lipid formulation.
    Mohr JF; Hall AC; Ericsson CD; Ostrosky-Zeichner L
    Pharmacotherapy; 2005 Mar; 25(3):426-8. PubMed ID: 15843289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of antifungal agents in the cornea. II. Influence of corticosteroids.
    O'Day DM; Ray WA; Robinson R; Head WS
    Invest Ophthalmol Vis Sci; 1984 Mar; 25(3):331-5. PubMed ID: 6321389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.